DR. REDDY'S LABORATORIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,240 INR | +2.82% |
|
+4.63% | +7.62% |
| 27/06 | Asian Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading | MT |
| 27/06 | Dr. Reddy's to Acquire Haleon's Nicotine Replacement Therapy Business Outside US | MT |
Dr. Reddy's Laboratories specializes in developing, producing, and selling pharmaceutical products. Net sales break down by activity as follows:
- sales of generic medications (79.9%): brand-name or generic prescription medications and OTC medicines;
- sales of active ingredients (15.7%). The group also supplies customized pharmaceutical services;
- other (4.4%): sales of generic biopharmaceutical products, development of molecular agents, etc.
Net sales are distributed geographically as follows: India (18.8%), the United States (45%), Russia (9.9%) and other (26.3%).
Sector
Pharmaceuticals
Calendar
16/07/2024
- Détachement de for final dividend
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
36
Last Close Price
6,240
INR
Average target price
6,149
INR
Spread / Average Target
-1.45%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +7.62% | 1.21TCr | |
| +55.95% | 81TCr | |
| +43.62% | 64TCr | |
| -6.98% | 35TCr | |
| +19.08% | 33TCr | |
| +9.05% | 30TCr | |
| +16.30% | 25TCr | |
| +2.41% | 22TCr | |
| +12.47% | 22TCr | |
| +8.91% | 17TCr |
- Stock Market
- Equities
- DRREDDY Stock
- News Dr. Reddy's Laboratories Limited
- Dr Reddy Laboratories' : Price Target From Nomura Raised to INR6,145 From INR5,065, Buy Rating Maintained
